Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 606 of 1,261
  1. US 9777050

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted
  2. CA 3018635

    UTILISATION DE MASITINIB POUR LE TRAITEMENT D'UNE SOUS-POPULATION DE PATIENTS ATTEINTS DE SCLEROSE LATERALE AMYOTROPHIQUE

    AB SCIENCE [FR] · Granted Sep 28, 2017 · Expires Sep 23, 2037

    granted
  3. US 9770504

    Generating peptoid vaccines

    The Board of Regents of the University of Texas System · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  4. US 9771337

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  5. US 9770427

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  6. US 9771376

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  7. US 9771414

    Human antibodies to ebola virus glycoprotein

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  8. US 9771338

    1,2,4-oxadiazole derivatives as immunomodulators

    Auirgene Discovery Technologies Limited · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  9. US 9771591

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  10. US 9771585

    miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)

    MIRAGEN THERAPEUTICS, INC. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  11. US 9771428

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  12. US 9771403

    Methods and compositions for treating hemophilia

    Sangamo Therapeutics, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  13. US 9771408

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  14. US 9771567

    Klotho variant polypeptides

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  15. US 9771366

    Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors

    PHOENIX MOLECULAR DESIGNS · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  16. US 9771361

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  17. US 9771350

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  18. US 9771358

    Dihydropyrimidine compounds and their application in pharmaceuticals

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  19. US 9771327

    Compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  20. US 9770519

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  21. US 9770510

    Etanercept formulations stabilized with xylitol

    Coherus BioSciences, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  22. US 9770507

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  23. US 9770500

    S-nitrosylation of glucosylating toxins and uses therefor

    The Board of Regents of the University of Texas System · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  24. US 9770469

    Methods of reprogramming renal cells

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.